Add this topic to your myFT Digest for news straight to your inbox
Also in this week’s newsletter, the unintended consequences of Brexit on migration
European Medicines Agency saddled with 15-year liability for lease after subtenant WeWork stops paying rent
US biotech has been struggling to overcome fall in demand for coronavirus jabs
EMA backs jabs targeting the strain that appeared in 2019 and original version of Omicron
Some people are travelling abroad to get vaccinated in wake of severe shortages and increasing case numbers
Europe may receive vaccines tailored to BA.4 and BA.5 sub-variants later than the US
Recommendation comes as highly transmissible BA.5 Omicron sub-variant drives up infections across continent
EMA said to be unlikely to grant marketing authorisation to molnupiravir this month after ‘problematic’ data
Bloc to get its fifth vaccine shot as US biotech targets 2bn doses in 2022
Chief of European drugs regulator says it will take time to reach consensus on variant-targeted vaccines
US drugmaker ‘confident’ as health bodies signal decisions on the horizon
Emer Cooke stressed that depending too heavily on a single shot could be self-defeating
Decision paves way for EU countries to start vaccinating school-age children
CDC and FDA recommendation comes after reports of ‘rare and severe’ blood clots
Incidence rate shows ‘no difference’ between genders, according to UK’s Commission on Human Medicines
European regulator also establishes link between jabs and rare blood clots
EMA team to investigate whether Russian studies followed global clinical and scientific guidelines
Regulators say shot is safe but UK records new clotting cases and growing number of countries restrict its use
Go-ahead for Halix-run factory is expected to increase supply of AstraZeneca jab to bloc
Questions mount over whether Soriot’s dash and drive, which enthral investors, have resulted in missteps
Germany, France, Spain and Italy reverse course after drugs regulator finds jab ‘safe and effective’
EU drugs regulator insists benefits of Covid vaccine ‘outweigh’ risks of side-effects
Order for further 300m doses follows regulatory advice that additional dose can be extracted from each vial
Decision follows recommendation from European Medicines Agency amid infections spike
First vaccinations expected to start across 27-member bloc within days
International Edition